Abstract: An in vitro method for the detection of inflammation caused by an acute COVID-19 infection, long COVID and/or PIMS. The level of kynurenine in a body fluid is determined and the value of kynurenine measured in the patient to be diagnosed is compared with the average value obtained from a comparable cohort of persons who do not suffer from said diseases, whereby the value of kynurenine in patients is increased.
Abstract: An in vitro method for the early detection of a potential inflammation, in particular a rejection of a transplant is disclosed, wherein the level of kynurenine in saliva is determined. The test method can be easily performed and allows the early detection of potential problems.
Type:
Grant
Filed:
May 2, 2014
Date of Patent:
May 29, 2018
Assignee:
Salion GmbH
Inventors:
Dietmar Abendroth, Manfred J Stangl, Michael Marzinzig
© 2024 Justia
